Mason Street Advisors’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-20,511
| Closed | -$399K | – | 1535 |
|
|
2018
Q1 | $399K | Buy |
20,511
+1,235
| +6% | +$24K | 0.01% | 1118 |
|
|
2017
Q4 | $321K | Buy |
19,276
+455
| +2% | +$7.58K | 0.01% | 1183 |
|
|
2017
Q3 | $382K | Buy |
18,821
+646
| +4% | +$13.1K | 0.01% | 1101 |
|
|
2017
Q2 | $293K | Buy |
18,175
+930
| +5% | +$15K | 0.01% | 1168 |
|
|
2017
Q1 | $218K | Buy |
17,245
+1,101
| +7% | +$13.9K | 0.01% | 1249 |
|
|
2016
Q4 | $214K | Buy |
16,144
+939
| +6% | +$12.4K | 0.01% | 1241 |
|
|
2016
Q3 | $360K | Buy |
15,205
+1,641
| +12% | +$38.9K | 0.01% | 1026 |
|
|
2016
Q2 | $391K | Buy |
13,564
+1,432
| +12% | +$41.3K | 0.01% | 973 |
|
|
2016
Q1 | $388K | Buy |
12,132
+1,449
| +14% | +$46.3K | 0.01% | 946 |
|
|
2015
Q4 | $457K | Buy |
10,683
+670
| +7% | +$28.7K | 0.01% | 905 |
|
|
2015
Q3 | $353K | Buy |
10,013
+802
| +9% | +$28.3K | 0.01% | 939 |
|
|
2015
Q2 | $423K | Buy |
9,211
+403
| +5% | +$18.5K | 0.01% | 922 |
|
|
2015
Q1 | $413K | Buy |
8,808
+284
| +3% | +$13.3K | 0.01% | 923 |
|
|
2014
Q4 | $270K | Buy |
8,524
+319
| +4% | +$10.1K | ﹤0.01% | 1415 |
|
|
2014
Q3 | $195K | Buy |
8,205
+15
| +0.2% | +$356 | ﹤0.01% | 1485 |
|
|
2014
Q2 | $246K | Buy |
8,190
+269
| +3% | +$8.08K | ﹤0.01% | 1430 |
|
|
2014
Q1 | $209K | Sell |
7,921
-2,368
| -23% | -$62.5K | ﹤0.01% | 1438 |
|
|
2013
Q4 | $259K | Buy |
10,289
+873
| +9% | +$22K | ﹤0.01% | 1448 |
|
|
2013
Q3 | $193K | Buy |
9,416
+401
| +4% | +$8.22K | ﹤0.01% | 1323 |
|
|
2013
Q2 | $180K | Buy |
+9,015
| New | +$180K | ﹤0.01% | 1254 |
|